Dilaudid and Vena cava thrombosis - a phase IV clinical study of FDA data

Summary:

Vena cava thrombosis is reported as a side effect among people who take Dilaudid (hydromorphone hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lipitor, and have Bleeding disorders.

The phase IV clinical study analyzes which people have Vena cava thrombosis when taking Dilaudid. It is created by eHealthMe based on reports of 95,518 people who have side effects when taking Dilaudid from the FDA, and is updated regularly.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.

What is Vena cava thrombosis?

Vena cava thrombosis (clotting of the blood in large vein carrying deoxygenated blood into the heart) is found to be associated with 284 drugs and 464 conditions by eHealthMe. Check the latest studies of Vena cava thrombosis.

On Jul, 08, 2026

95,518 people reported to have side effects when taking Dilaudid.
Among them, 42 people (0.04%) have Vena cava thrombosis.

Could Dilaudid cause Vena cava thrombosis?

Among these 42 people:

How long have people been on Dilaudid when they have Vena cava thrombosis? *

What is the gender of people who have Vena cava thrombosis when taking Dilaudid? *

female: 57.89 %
male: 42.11 %

What is the age of people who have Vena cava thrombosis when taking Dilaudid? *

What are other drugs people take besides Dilaudid? *

What are other side effects people have besides Vena cava thrombosis? *

Pulmonary Embolism (blockage of the main artery of the lung): 19 people, 45.24%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 12 people, 28.57%
High Blood Pressure: 12 people, 28.57%
Feeling Abnormal: 12 people, 28.57%
General Physical Health Deterioration (weak health status): 10 people, 23.81%
Oedema Peripheral (superficial swelling): 10 people, 23.81%
Diarrhea: 10 people, 23.81%
Weight Decreased: 9 people, 21.43%
Joint Pain: 9 people, 21.43%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 9 people, 21.43%

What are the existing conditions these people have? *

High Blood Cholesterol: 9 people, 21.43%
Cardiac Discomfort: 9 people, 21.43%
Glomerulonephritis Membranous (nephritis with inflammation of the capillary loops in the renal glomeruli): 9 people, 21.43%
Diabetes: 9 people, 21.43%
Insomnia (sleeplessness): 9 people, 21.43%
Bleeding Disorders: 9 people, 21.43%
Multiple Myeloma (cancer of the plasma cells): 8 people, 19.05%
Pancreatic Carcinoma (pancreatic cancer): 7 people, 16.67%
Thrombosis (formation of a blood clot inside a blood vessel): 7 people, 16.67%
Traumatic Haemorrhage (a bleeding due to trauma): 5 people, 11.90%

* Approximation only. Some reports may have incomplete information.

Do you take Dilaudid and have Vena cava thrombosis?

- Check whether Vena cava thrombosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dilaudid:

Dilaudid (96,466 reports)

Browse all side effects of Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vena cava thrombosis:

Vena cava thrombosis (284 drugs)

Browse all the conditions that are associated with Vena cava thrombosis:

Vena cava thrombosis (464 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydromorphone hydrochloride (the active ingredients of Dilaudid) and Dilaudid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.